A Phase 1 interventional study of aspirin and warfarin in Ischemic Stroke, sponsored by University of California, San Diego. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-12-08.
Sponsored by University of California, San Diego · Phase 1, Interventional, and Treatment
Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.
20 patients with cervicocephalic arterial dissection will be randomized to open-label aspirin or warfarin, rate of stroke and adverse events will be endpoints.
2,593 studies on the registry are indexed under Ischemic Stroke; 930 are open to participants now.
Browse Ischemic Stroke studies →University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.
Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: aspirin
Drug: warfarin
Incidence of stroke by one year.
Time frame: 1 year
Recurrent dissection by one year.
Time frame: 1 year
Incidence of TIA by one year.
Time frame: 1 year
Incidence of major and minor bleeding episodes by one year.
Time frame: 1 year
This study is withdrawn, as verified in Mar 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, San Diego